These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2869728)

  • 1. Treatment of severe reflux esophagitis.
    Richter JE
    Ann Intern Med; 1986 Apr; 104(4):588-9. PubMed ID: 2869728
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical management of reflux esophagitis.
    Vantrappen G; Janssens J
    Digestion; 1985; 32 Suppl 1():51-8. PubMed ID: 2866136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical therapy for reflux esophagitis: 1986 and beyond.
    Castell DO
    Ann Intern Med; 1986 Jan; 104(1):112-4. PubMed ID: 2866742
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of reflux oesophagitis.
    Wesdorp IC
    Scand J Gastroenterol Suppl; 1982; 79():106-19. PubMed ID: 6131532
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug therapy of reflux oesophagitis: an update.
    Tytgat GN
    Scand J Gastroenterol Suppl; 1989; 168():38-49. PubMed ID: 2575792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper gastrointestinal motility. Part I--The pathophysiologic approach to the management of reflux esophagitis.
    Holloway RH; Winnan G; McCallum RW
    Am J Gastroenterol; 1981 Sep; 76(3):280-90. PubMed ID: 6119024
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical measures that influence the gastroesophageal junction.
    Castell DO
    South Med J; 1978 Jan; 71 Suppl 1():26-8. PubMed ID: 24274
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical therapy of reflux esophagitis.
    Castell DO
    Ann Intern Med; 1980 Dec; 93(6):926-7. PubMed ID: 7004295
    [No Abstract]   [Full Text] [Related]  

  • 9. The medical therapy of reflux oesophagitis.
    Tytgat GN; Nio CY
    Baillieres Clin Gastroenterol; 1987 Oct; 1(4):791-807. PubMed ID: 2896523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastroesophageal reflux disease and reflux esophagitis. Therapeutic modifiability by bethanechol chloride].
    Hunold W
    ZFA (Stuttgart); 1982 Oct; 58(29):1623-8. PubMed ID: 6129755
    [No Abstract]   [Full Text] [Related]  

  • 11. Drugs, foods, and other substances in the cause and treatment of reflux esophagitis.
    Richter JE; Castell DO
    Med Clin North Am; 1981 Nov; 65(6):1223-34. PubMed ID: 7035766
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical management of patients with reflux esophagitis.
    Roufail WM
    South Med J; 1978 Jan; 71 Suppl 1():43-4. PubMed ID: 628873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bethanechol or cimetidine in the treatment of symptomatic reflux esophagitis: a double-blind control study.
    Thanik K; Chey WY; Shak A; Hamilton D; Nadelson N
    Arch Intern Med; 1982 Aug; 142(8):1479-81. PubMed ID: 6125135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials.
    Koelz HR
    Scand J Gastroenterol Suppl; 1989; 156():25-36. PubMed ID: 2568015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroesophageal reflux: diagnosis and management.
    Richter JE
    Hosp Pract (Off Ed); 1992 Jan; 27(1):59-66. PubMed ID: 1346142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reflux esophagitis: an update.
    Nelson JL; Castell DO
    South Med J; 1985 Apr; 78(4):452-7. PubMed ID: 2858922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of H2 receptor antagonist with proton pump inhibitor is effective for long-term control of refractory reflux esophagitis.
    Adachi K; Komazawa Y; Mihara T; Fujishiro H; Ishihara S; Amano Y; Kinoshita Y
    J Clin Gastroenterol; 2004 Mar; 38(3):297-8. PubMed ID: 15128081
    [No Abstract]   [Full Text] [Related]  

  • 19. H2 antagonists in the treatment of reflux esophagitis: a critical analysis.
    Stalnikowicz-Darvasi R
    Am J Gastroenterol; 1989 Mar; 84(3):245-8. PubMed ID: 2563926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical review of current medical therapy for gastroesophageal reflux disease.
    Richter JE
    J Clin Gastroenterol; 1986; 8 Suppl 1():72-80. PubMed ID: 2874168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.